Search / 77 results found

from
to
  • Updated

Rep. Tina Polsky, D-Boca Raton, debates during a session Tuesday March 10, 2020, in Tallahassee, Fla. Florida's top health official was asked to leave a meeting after refusing to wear a mask at the office of the state senator who told him she had a serious medical condition, officials have confirmed. Florida Senate leader Wilton Simpson, a Republican, sent a memo to senators Saturday, Oct. 23, 2021 regarding the incident at the office of Democratic state Sen. Tina Polsky, asking visitors at the building to be respectful with social interactions. Polsky, who represents parts of Broward and Palm Beach counties, had not yet made public her breast cancer diagnosis. (AP Photo/Steve Cannon)

Region
AP
  • Updated

This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (Pfizer via AP)

Region
AP
  • Updated

This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (Pfizer via AP)

Region
AP
  • Updated

This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (Pfizer via AP)

Region
AP
  • Updated

This October 2021 photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday, Oct. 22, as the U.S. considers opening vaccinations to that age group. (Pfizer via AP)